June 2022Volume 175, Issue 6
June 2022Volume 175, Issue 6
ORIGINAL RESEARCH
1. Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds
2. Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease
- A Case-Crossover Study
3. International Validation of the Canadian Syncope Risk Score
- A Cohort Study
4. Changes in Health Care Spending, Use, and Clinical Outcomes After Nonfatal Firearm Injuries Among Survivors and Family Members
- A Cohort Study
5. Homicide Deaths Among Adult Cohabitants of Handgun Owners in California, 2004 to 2016
- A Cohort Study
6. Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation
7. Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction
- A Post Hoc Analysis of the DAPA-HF Trial
8. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments
- A Retrospective Cohort Study
REVIEWS
9. Effectiveness of Motivational Interviewing in Managing Overweight and Obesity
- A Systematic Review and Meta-analysis
10. Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure
- A Systematic Review and Meta-analysis
BEYOND THE GUIDELINES
11. Would You Recommend a Statin to This Patient for Primary Prevention of Cardiovascular Disease?
- Grand Rounds Discussion From Beth Israel Deaconess Medical Center
ACADEMIA AND THE PROFESSION
12. Affirmative Action Bans and Enrollment of Students From Underrepresented Racial and Ethnic Groups in U.S. Public Medical Schools
MEDICINE AND PUBLIC ISSUES
13. Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System Experience
IDEAS AND OPINIONS
14. A Patient Price Guide for Prescription Medication
15. Now Is the Time to Make Screening for Lung Cancer Reportable
16. Direct-to-Consumer Generic Drugs: A Maverick Approach or Another Exposure of Market Failures?
17. Belt and Suspenders: Vaccines and Tixagevimab/Cilgavimab for Prevention of COVID-19 in Immunocompromised Patients
EDITORIALS
18. Diabetes Screening: Different Thresholds for Different Racial/Ethnic Groups
19. Firearm Injury in the United States: Time to Confront It as the Epidemic It Has Become
20. Nonoperative Management of Mild Primary Hyperparathyroidism: A Reasonable, Evidence-Based Option
21. Increasing Motivation for Lifestyle Change Is Not Enough to Treat Obesity
ON BEING A DOCTOR
22. Professional Courtesy
ON BEING A PATIENT
23. My Patient Portal
LETTERS
24. Implementation of a SARS-CoV-2 Genotyping Panel for Prompt Omicron Variant Identification: A Pragmatic Tool for Clinical Laboratories
- Observation: Brief Research Reports
25. The Emperor Has No Ganey
- Comment
- Response
CORRECTIONS
26. Correction: Improving Glomerular Filtration Rate Estimation—Across the Age and Diversity Spectrum
27. Correction: Summary for Patients: Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Death
AD LIBITUM
28. Appearance
IN THE CLINIC
29. Prevention and Initial Management of HIV Infection
ACP JOURNAL CLUB
30. USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF
31. In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death
32. In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care reduced all-cause mortality
33. In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y
34. In nonischemic systolic HF, prophylactic ICDs did not reduce all-cause mortality vs. usual care at 10 y
35. In acute stroke with a large ischemic region, endovascular therapy improved functional status at 90 d
36. In Black and Latinx patients, as-needed inhaled glucocorticoids reduced asthma exacerbations at 15 mo
37. Patients surviving COVID-19 had increased risk for adverse mental health outcomes vs. persons without COVID-19
38. Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis
39. In knee OA, PT vs. glucocorticoid injections had an incremental cost-effectiveness ratio of $35 527/QALY gained
WEB EXCLUSIVES
40. Annals Graphic Medicine - Dr. Mom: Medical Conference
41. Annals Graphic Medicine - Swanorexia
42. Annals for Educators - June 2022
43. Annals for Hospitalists Inpatient Notes - Venous Thromboembolism Prophylaxis in COVID-19: Making Sense of the Evidence
SUMMARIES FOR PATIENTS
44. Summary for Patients: Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments
45. Summary for Patients: Mortality and Morbidity in Mild Primary Hyperparathyroidism
46. Summary for Patients: Homicide Deaths Among Adults Living With Handgun Owners in California
47. Summary for Patients: Risk for Unwanted Outcomes in Men Prescribed Both Drugs for Erectile Dysfunction and Nitrates for Angina
48. Summary for Patients: Screening for Diabetes by Race and Ethnicity in the United States